• Return to Headlines

Synta Pharmaceuticals Leads the Companies in the Biotechnology Industry Offering Investors Top Value (SNTA, FOLD, AFFY, GTXI, CYTK)

Written on Fri, 07/23/2010 - 3:11am
By Chip Brian

Below are the top five companies in the Biotechnology industry as measured by the price to sales per share ratio. Often companies with the lowest ratio present the greatest value to investors.
Synta Pharmaceuticals (NASDAQ:SNTA) has a price/sales ratio of 0.69x based on a current price of $2.93 and trailing 12-month sales per share of $4.23.
Amicus Therapeutics (NASDAQ:FOLD) has a price/sales ratio of 0.99x based on a current price of $2.61 and trailing 12-month sales per share of $2.64.
Affymax (NASDAQ:AFFY) has a price/sales ratio of 1.04x based on a current price of $6.23 and trailing 12-month sales per share of $5.97.
GTx (NASDAQ:GTXI) has a price/sales ratio of 1.63x based on a current price of $3.03 and trailing 12-month sales per share of $1.86.
Cytokinetics (NASDAQ:CYTK) has a price/sales ratio of 1.66x based on a current price of $2.31 and trailing 12-month sales per share of $1.39.
SmarTrend is bearish on shares of AFFY and our subscribers were alerted to Sell on June 01, 2010 at $20.34. The stock has fallen 69.4% since the alert was issued.

Keywords: synta pharmaceuticals price to sales ratio

Ticker(s): SNTA FOLD AFFY GTXI CYTK

Contact Chip Brian



Smartrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.mysmartrend.com.

Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at http://www.mysmartrend.com/morning-call-newsletter-signup.